Teewinot gets US patent for bioreactor used to make synthetic cannabinoid APIs
Teewinot Life Sciences has been granted a US patent for a bioreactor it uses to produce synthetic cannabinoids.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs